✦ LIBER ✦

Current Directions in Systemic Therapy for Gastrointestinal Stromal Tumors

✍ Scribed by Rashmi Chugh

Book ID: 116396117
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 553 KB
Volume: 35
Category: Article
ISSN: 0147-0272
DOI: 10.1016/j.currproblcancer.2011.10.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systemic therapy for advanced gastrointe

Systemic therapy for advanced gastrointestinal stromal tumors: Beyond imatinib

✍ Edward J. Kim; Mark M. Zalupski 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract Progression on first‐line therapy with imatinib in gastrointestinal stromal tumors (GIST) is caused by either initial resistance or more often a secondary mutation in tyrosine kinases KIT or PDGFR. Therapies in development for imatinib‐resistant GIST include agents that target KIT/PDGFR

Recent advances in therapy for gastroint

Recent advances in therapy for gastrointestinal stromal tumors

✍ Robert G. Maki 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 273 KB

Targeted therapy for gastrointestinal st

Targeted therapy for gastrointestinal stromal tumors: current status and future perspectives

✍ Georgios S. Papaetis; Kostas N. Syrigos 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 402 KB

Adjuvant imatinib therapy for gastrointe

Adjuvant imatinib therapy for gastrointestinal stromal tumors

✍ Peter W.T. Pisters; Chiara Colombo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Advances in Adjuvant Therapy of Gastroin

Advances in Adjuvant Therapy of Gastrointestinal Stromal Tumors

✍ K. Adekola, M. Agulnik 📂 Article 📅 2012 🏛 Current Science Inc. 🌐 English ⚖ 147 KB

Current clinical strategy for imatinib-r

Current clinical strategy for imatinib-resistant gastrointestinal stromal tumors

✍ Masayoshi Yamamoto; Hiroyuki Konno 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 231 KB